摘要:
Disclosed is a compound represented by the following general formula (I) (wherein R1 represents an aryl group having 6-10 carbon atoms or a heteroaryl group which may have, as a substituent, a group selected from an alkyl group having 1-8 carbon atoms, an alkyl group having 1-8 carbon atoms which is substituted with a halogen atom, an alkoxy group having 1-8 carbon atoms, an alkoxy group having 1-8 carbon atoms which is substituted with an alkoxy group having 1-8 carbon atoms, an alkoxycarbonyl group having 2-8 carbon atoms, a formyl group, a carboxyl group, a halogen atom, a hydroxyl group, a nitro group, a cyano group, an amino group, an aryl group having 6-10 carbon atoms and an aryloxy group having 6-10 carbon atoms; R2 represents a cyano group, a nitro group or the like; R3 represents an hydroxyl group or the like; X represents an oxygen atom, a sulfur atom or the like; and Y represents an oxygen atom or a sulfur atom). Also disclosed is a xanthine oxidase inhibitor containing such a compound.
摘要:
The invention relates to compounds of the following formula (I) or their salts:
in which R 1 is a group of phenyl, naphthyl, pyridyl or the like which may have a substituent such as an alkyl group having 1-8 carbon atoms, an alkoxy group having 1-8 carbon atoms, an alkoxycarbonyl group having 2-8 carbon atoms, carboxyl, halogen, hydroxyl, nitro, or cyano; R 2 is cyano, nitro, or the like; R 3 is hydroxyl or the like; X is oxygen, sulfur, or the like; and Y is oxygen or sulfur, and a xanthine oxidase inhibitor containing the compound.
摘要翻译:本发明涉及下式(I)的化合物或其盐:其中R 1是可具有取代基的苯基,萘基,吡啶基等基团,例如具有1-8个碳原子的烷基, 具有1-8个碳原子的烷氧基,具有2-8个碳原子的烷氧基羰基,羧基,卤素,羟基,硝基或氰基; R 2是氰基,硝基等; R 3是羟基等; X是氧,硫等; Y为氧或硫,含有该化合物的黄嘌呤氧化酶抑制剂。
摘要:
A P2X 4 receptor antagonist is a compound represented by the formula (I) or a pharmacologically acceptable salt thereof, which is used as a preventive or therapeutic agent for neuropathic pains:
Wherein B is aryl or the like that can have a substituent; Y is C 1-5 alkylene that can have a double bond; Z is O, S or the like; each of R 1 , R 2 and R 3 independently is hydrogen, C 1-8 alkyl or the like; R 4 is hydrogen, C 1-8 alkyl or the like; each of P and Q independently is hydrogen, halogen, C 1-8 alkyl or the like; W is C 1-8 alkyl or the like; and each of n and m independently is 1 or 2.
摘要翻译:P2X 4受体拮抗剂是由式(I)表示的化合物或其药理学上可接受的盐,其用作神经性疼痛的预防或治疗剂:其中B是可以具有取代基的芳基等; Y是可以具有双键的C 1-5亚烷基; Z是O,S等; R 1,R 2和R 3各自独立地为氢,C 1-8烷基等; R 4为氢,C 1-8烷基等; P和Q各自独立地为氢,卤素,C 1-8烷基等; W是C 1-8烷基等; n和m各自独立地为1或2。
摘要:
A compound having the following formula (II) or its salt is used as an activator for PPAR δ:
[in which W 3 is a nitrogen atom or CH; Z 1 is an oxygen atom or a sulfur atom; each of R 11 and R 12 is a hydrogen atom, a halogen atom, a C 1 -C 8 alkyl group, a C 1 -C 8 alkoxy group, a C 1 -C 8 alkyl group having a halogen substituent, or the like; each of R 13 and R 14 is a hydrogen atom or a C 1 -C 8 alkyl group; A 1 is pyrazole or thiophene which may have a substituent; and m is an integer of 2 to 4].
摘要翻译:使用具有下式(II)或其盐的化合物作为PPAR'的活化剂:[其中W 3为氮原子或CH; Z 1是氧原子或硫原子; R 11和R 12各自为氢原子,卤素原子,C 1〜C 8烷基,C 1〜C 8烷氧基,具有卤素取代基的C 1〜C 8烷基等 ; R 13和R 14各自为氢原子或C 1 -C 8烷基; A 1是可以具有取代基的吡唑或噻吩; m为2〜4的整数]。
摘要:
A compound having the following formula or its salt is used as an activator for PPAR:
[in which W 2 represents a bond, C(C=O) or CH 2 ; Z 2 represents an oxygen or sulfur atom; R 21 , R 22 and R 23 independently represent a hydrogen atom, an alkyl group having 1 to 8 carbon atoms, an alkoxy group having 1 to 8 carbon atoms, a halogen atom, an alkyl group having 1 to 8 carbon atoms which is substituted with a halogen atom or the like; and R 24 and R 25 independently represent a hydrogen atom, an alkyl group having 1 to 8 carbon atoms or an alkyl group having 1 to 8 carbon atoms which is substituted with a halogen atom].
摘要翻译:具有下式的化合物或其盐用作PPAR的活化剂:[其中W 2表示键,C(C = O)或CH 2; Z 2表示氧或硫原子; R 21,R 22和R 23独立地表示氢原子,碳原子数1〜8的烷基,碳原子数1〜8的烷氧基,卤素原子,碳原子数1〜8的烷基,被取代的 与卤素原子等; R 24和R 25独立地表示氢原子,碳原子数1〜8的烷基或被卤素原子取代的碳原子数1〜8的烷基。
摘要:
A compound or its salt having the following formula (II) is used as an activator for PPAR δ:
[in which each of R 11 and R 13 is a hydrogen atom, an alkyl group having 1 to 8 carbon atoms, an alkoxy group having 1 to 8 carbon atoms, an alkyl group having 1 to 8 carbon atoms and a halogen atom substituent, etc.; R 12 is a hydrogen atom, an alkyl group having 1 to 8 carbon atoms, an alkoxy group having 1 to 8 carbon atoms, an alkyl group having 1 to 8 carbon atoms and a halogen atom substituent, etc.; each of R 14 and R 15 is a hydrogen atom, an alkyl group having 1 to 8 carbon atoms, or an alkyl group having 1 to 8 carbon atoms and a halogen atom substituent; X 1 is CH or N; Z 1 is an oxygen atom or a sulfur atom; W 1 is an oxygen atom or CH 2 ; and q is an integer of 2 to 4].
摘要翻译:使用具有下式(II)的化合物或其盐作为PPAR'的活化剂:[其中R 11和R 13各自为氢原子,具有1至8个碳原子的烷基,具有 1〜8个碳原子的烷基,碳原子数1〜8的烷基和卤素原子取代基等。 R 12为氢原子,碳原子数1〜8的烷基,碳原子数1〜8的烷氧基,碳原子数1〜8的烷基和卤原子取代基等。 R 14和R 15各自为氢原子,碳原子数1〜8的烷基或碳原子数1〜8的烷基和卤素原子取代基。 X 1为CH或N; Z 1是氧原子或硫原子; W 1是氧原子或CH 2; q为2〜4的整数]。
摘要:
A compound represented by the following general formula (II) or a salt thereof is used as an activator of PPARδ.
wherein G a is O, CH 2 or the like; A a is thiazole, oxazole, or thiophene, which can have a substituent such as C 1-8 alkyl, C 1-8 alkoxy, halogen, C 1-8 alkyl substituted with halogen or the like; B a is a C 1-8 alkylene or C 2-8 alkenylene chain; and each of R 1a and R 2a independently is hydrogen, C 1-8 alkyl, C 1-8 alkoxy, halogen, C 1-8 alkyl substituted with halogen or the like.
摘要翻译:使用由以下通式(II)表示的化合物或其盐作为PPAR'的活化剂。 其中G a是O,CH 2等; A是可以具有取代基的噻唑,恶唑或噻吩,例如C 1-8烷基,C 1-8烷氧基,卤素,被卤素取代的C 1-8烷基等; B a是C 1-8亚烷基或C 2-8亚烯基链; R 1a和R 2a各自独立地为氢,C 1-8烷基,C 1-8烷氧基,卤素,被卤素取代的C 1-8烷基等。
摘要:
Compounds represented by the general formula (I), and xanthine oxidase inhibitors containing the same as the active ingredient: (I) wherein R1 is OR4 or the like (wherein R4 is optionally substituted C1-8 alkyl or the like); R2 is halogeno, nitro, cyano, carboxyl, or the like; R3 is hydrogen, halogeno, hydroxyl, amino, carboxyl, or the like; X is NR11, oxygen, or sulfur (wherein R11 is hydrogen or optionally substituted C1-8 alkyl); and Y and Z are each CR12 or nitrogen (wherein R12 is the same as defined for R3).
摘要:
The invention relates to compounds of the following formula (I) or their salts: in which R 1 represents OR 4 or others, in which R 4 is an alkyl group having 1-8 carbon atoms which may have a substituent or the like; R 2 is halogen, nitro, cyano, carboxyl, or the like; R 3 is hydrogen, halogen, hydroxyl, amino, carboxyl, or the like; X is NR 11 , oxygen, or sulfur, in which R 11 is hydrogen, or an alkyl group having 1-8 carbon atom which may have a substituent; and each of Y and Z is CR 12 or nitrogen, in which R 12 has the same meaning as R 3 above, and a xanthine oxidase inhibitor containing the compound as an active ingredient.
摘要翻译:本发明涉及下式(I)的化合物或其盐:其中R 1表示OR 4或其它的其中R 4为具有1-8个碳原子的烷基的CHEM 可以具有取代基等; R 2是卤素,硝基,氰基,羧基等; R 3是氢,卤素,羟基,氨基,羧基等; X是NR 11,氧或硫,其中R 11是氢,或具有1-8个碳原子的可以具有取代基的烷基; Y和Z各自为CR 12或氮,其中R 12具有与上述R 3相同的含义,和含有该化合物作为活性成分的黄嘌呤氧化酶抑制剂。